These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Choice of antihypertensive agent--insignificant role of doxazosin (Alfadil). How are evidence-based recommendations implemented?]. Gustafsson LL Lakartidningen; 2004 Jan; 101(3):228-9. PubMed ID: 14763097 [No Abstract] [Full Text] [Related]
4. [Doxazosin and heart failure: a clinical conclusion is wanted]. Järhult B; Lindahl SO Lakartidningen; 2003 Dec; 100(51-52):4328. PubMed ID: 14756102 [No Abstract] [Full Text] [Related]
5. [Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension]. Janssen CA Ned Tijdschr Geneeskd; 2003 Jan; 147(3):135; author reply 135-6. PubMed ID: 12577776 [No Abstract] [Full Text] [Related]
6. [Alfadil--positive documentation when it comes to safety is missing]. Furberg C Lakartidningen; 2003 Dec; 100(51-52):4329; discussion 4330. PubMed ID: 14756103 [No Abstract] [Full Text] [Related]
7. Diuretics vs alpha-blockers for treatment of hypertension: lessons from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Lasagna L JAMA; 2000 Apr; 283(15):2013-4. PubMed ID: 10789671 [No Abstract] [Full Text] [Related]
8. On call. I'm a 76-year-old man with an enlarged prostate. I've been taking Cardura and it's helped a lot, but my doctor stopped it because he said a study found the drug could cause heart failure. Now I'm getting up three or four times a night again. Is Cadura safe? Simon HB Harv Mens Health Watch; 2001 Jul; 5(12):8. PubMed ID: 11511462 [No Abstract] [Full Text] [Related]
9. [Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension]. Hoogenberg K; van der Tuin J Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2099-100. PubMed ID: 12448967 [TBL] [Abstract][Full Text] [Related]
10. [Possibility of predicting the use of doxazosin in the treatment of arterial hypertension]. Khlynova OV; Tuev AV; Agafonov AV; Shkliaeva LN Klin Med (Mosk); 2003; 81(10):48-50. PubMed ID: 14664175 [TBL] [Abstract][Full Text] [Related]
11. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension. Ceral J; Solar M Blood Press; 2009; 18(1-2):74-7. PubMed ID: 19353415 [TBL] [Abstract][Full Text] [Related]
12. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis. Einhorn PT; Davis BR; Massie BM; Cushman WC; Piller LB; Simpson LM; Levy D; Nwachuku CE; Black HR; Am Heart J; 2007 Jan; 153(1):42-53. PubMed ID: 17174636 [TBL] [Abstract][Full Text] [Related]
13. [ALLHAT Study: doxazosin arm is discontinued. Alpha blocker is less effective than a diuretic]. Einecke D MMW Fortschr Med; 2000 Mar; 142(13):4-5. PubMed ID: 10783613 [No Abstract] [Full Text] [Related]
14. [Use of doxazosin (Cardura-Pfizer), alpha 1-adrenoreceptor antagonist, in treatment of hypertension in patients with diabetes]. Grzeszczak W Wiad Lek; 1998; 51 Suppl 2():5-10. PubMed ID: 9686527 [TBL] [Abstract][Full Text] [Related]
15. National Heart, Lung, and Blood Institute halts part of antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). SoRelle R Circulation; 2000 Mar; 101(12):E9025. PubMed ID: 10736305 [No Abstract] [Full Text] [Related]
16. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R; Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474 [TBL] [Abstract][Full Text] [Related]
18. Doxazosin arm of the ALLHAT study discontinued: how equal are antihypertensive drugs? Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial. Messerli FH; Grossman E Curr Hypertens Rep; 2000 Jun; 2(3):241-2. PubMed ID: 10981155 [No Abstract] [Full Text] [Related]